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Summary  
Activation of natural killer cells can be mediated by different receptors. Stimulation of the receptors 
2B4, NTB-A and CRACC, members of the SLAM-related receptor family, induces cytotoxicity and 
cytokine production. The surface expression of 2B4 and other activating natural killer cell receptors 
is down-modulated after receptor engagement, which results in a weaker response to consecutive 
stimulation. We tested whether this regulatory mechanism applies to all SLAM-related receptors 
expressed by primary human natural killer cells. After co-culture with target cells expressing the 
respective ligands different effects on receptor surface expression were observed. While 2B4 ex-
pression was strongly reduced, NTB-A showed less prominent down-modulation and the expression 
level of CRACC remained unchanged. The expression levels of the receptor-proximal signaling 
molecules SAP, EAT-2 and FynT did not change after receptor engagement. Co-culture with target 
cells expressing the ligands for NTB-A or CRACC had no impact on subsequent NTB-A or 
CRACC-mediated NK cell activation. 
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Introduction 
Natural killer cells are the third major lym-
phocyte population besides T and B cells. 
They are capable of eliminating infected or 
transformed cells and can shape immune an-
swers by secreting cytokines. Unlike T and B 
cells their activation is not dependent on one 
clonally expressed receptor, but on the inter-
play of a variety of activating and inhibitory 
receptors [1]. 
Among the activating receptors expressed on 
human NK cells are 2B4 (CD244), NTB-A 
and CRACC (CS1, CD319) [2]. These recep-
tors belong to the family of SLAM-related 
receptors, which is part of the Ig-like receptor 
superfamily [3]. With the exception of 2B4 
that binds to CD48, all family members are 
homophilic [4]. Ligation of these receptors 
can trigger NK cell cytotoxicity and cytokine 
secretion [5]. Their intracellular part contains 
two (NTB-A and CRACC) or four (2B4) im-
munoreceptor tyrosine-based switch motifs 
(ITSM), which become phosphorylated by 
src-family kinases after receptor engagement 
[6-9]. Phosphorylated ITSM are binding sites 
for the adapter proteins SLAM-associated 
protein (SAP) and EWS/FLI1 activated tran-
script 2 (EAT-2), two molecules that consist 
of one single Src homology 2 (SH2)-domain 
and a short C-terminal extension [10]. While 
2B4 and NTB-A bind both adapter molecules 
[7, 11-13], CRACC signaling is mediated 
solely by EAT-2 [9]. SAP has been shown to 
recruit the src-family kinase FynT to activated 
receptors [14, 15]. Association of FynT with 
SAP leads to activation of LAT, Vav-1, 
PLC-γ, c-Cbl, Grb2 and SHIP [6, 16, 17]. The 
down-stream effectors that are recruited by 
EAT-2 are still unknown [18]. 
We have recently shown that in primary NK 
cells and the cell line YTS surface expression 
of 2B4 is reduced after receptor engagement 
[19]. This down modulation resulted in de-
creased 2B4-mediated cytotoxicity in subse-
quent assays. Reduction of surface expression 
is not only mediated by rapid receptor inter-
nalization, but also by decrease of gene tran-
scription [20]. Similar regulation of surface 
expression has been reported for other activat-
ing NK cell receptors e.g. NKG2D [21, 22], 
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NKp46 [19, 23] and DNAM-1 [24] and seems 
to be a common regulatory mechanism. Apart 
from changes in receptor surface expression 
modulation can also take place at the level of 
expression of receptor-proximal signaling 
molecules. Chronic NKG2D stimulation re-
duces the expression level of the signaling 
adapter proteins DAP10 and DAP12 [25] and 
IL-2 activation of resting NK cells leads to 
up-regulation of SAP expression [26]. Also, 
some viral immune escape mechanisms rely 
on interference with receptor proximal signal-
ing molecules. Cytotoxicity mediated by the 
receptor NKp30 is impaired during infection 
with human cytomegalovirus, because the vi-
ral protein pp65 causes dissociation of the 
signaling adapter, the CD3-ζ chain, from the 
receptor [27]. 
In this study we investigated the regulation of 
2B4, NTB-A and CRACC surface expression 
on primary NK cells after receptor engage-
ment. We found strong down-regulation of 
2B4, a less pronounced effect on NTB-A ex-
pression and no change of CRACC expres-
sion. The expression level of the signaling 
molecules SAP, EAT-2 and FynT was unal-
tered after stimulation of either of the recep-
tors. Although the surface expression of NTB-
A was diminished, we found no impairment 
of cytotoxicity mediated by this receptor. 
Results and Discussion 
As the surface expression and function of 2B4 
is modulated upon ligand engagement, we 
wanted to test if the structurally and function-
ally related receptors NTB-A and CRACC 
show a similar behavior. To stimulate the re-
ceptors 2B4, NTB-A, and CRACC with their 
respective ligands, we used stably transfected 
BA/F3 cells expressing CD48, NTB-A, and 
CRACC, respectively (Fig. 1A). As negative 
control we used GFP expressing BA/F3 cells. 
While NTB-A and CD48 were expressed at 
high levels in the BA/F3 cells, CRACC sur-
face expression was rather low. However, this 
expression level of CRACC is well compara-
ble with that found on human NK cells ([28] 
and Fig. 1B) and other immune cells ([28] and 
data not shown). As 2B4, NTB-A and 
CRACC are homogenously expressed by all 
human NK cells, we used IL-2 expanded pri-
mary human NK cells for subsequent experi-
ments. 
 
Figure 1: Changes in receptor surface expression 
after receptor engagement 
(A) Surface expression of NTB-A, CD48 and CRACC 
on the stably transfected BA/F3 cells was analyzed by 
flow-cytometry. Gray histograms represent staining 
with a control antibody. (B) IL-2-expanded primary 
NK cells were co-cultured for 24 h with BA/F3 cells 
expressing CD48, NTB-A, CRACC or GFP as a nega-
tive control. After co-culture NK cells were stained 
with antibodies against 2B4, NTB-A and CRACC. One 
representative staining is shown in. The light gray his-
togram represents staining of NK cells from the co-
culture with a control antibody. (C) Relative fluores-
cence indices (RFI) have been calculated from twelve 
independent experiments. The mean RFI ±SD are 
shown. Statistical analysis was performed using one-
way ANOVA and Dunnet’s multiple comparison post-
test. 
To investigate the ligand-induced modulation 
of 2B4, NTB-A and CRACC surface expres-
sion we performed co-culture experiments of 
primary human NK cells with BA/F3 cells 
expressing CD48, NTB-A, CRACC or GFP 
as a negative control. After 24 hours of co-
culture NK cell surface expression of 2B4, 
NTB-A and CRACC was analyzed by flow-
cytometry (Fig. 1B,C). Contact with GFP-
expressing BA/F3 cells led to no major altera-
tion in expression levels compared to NK 
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cells cultured alone (Fig. 1B). When 2B4 was 
engaged by its ligand CD48 on the BA/F3 
cells, its surface expression was strongly re-
duced after co-culture (Fig. 1B), consistent 
with our previous data [19]. The expression of 
NTB-A was likewise decreased after contact 
with NTB-A-expressing cells, although the 
reduction was not as pronounced. Data ob-
tained in twelve independent experiments 
with NK cells from different donors showed 
that this effect was statistically significant 
(Fig. 1C). There was no considerable differ-
ence in expression levels of CRACC between 
NK cells from co-cultures with cells express-
ing GFP or CRACC (Fig. 1B). While we 
could observe a slight reduction of CRACC 
surface expression in some donors with 
higher expression levels, donors showing 
lower expression levels did not show this ef-
fect, and overall there was no statistically sig-
nificant ligand-induced down-regulation of 
CRACC (Fig. 1C). Also, the down-
modulation of one receptor after stimulation 
was specific as the expression levels of the 
other receptors remained unchanged 
(Fig. 1C). These data demonstrate that there 
are clear differences in the ligand-induced 
down-modulation between the different 
SLAM-related receptors.  
 
 
Figure 2: Expression levels of receptor-proximal 
signaling molecules are unchanged 
Co-cultures were performed as described for figure 1. 
NK cells were re-isolated using anti-CD56-coated 
magnetic beads and lysed. Cell lysates were analyzed 
by western blotting. Membranes were probed with an-
tibodies against the indicated proteins. The blot shown 
is representative for at least two experiments 
While 2B4 and NTB-A expression are both 
subject to down-modulation after receptor en-
gagement, CRACC expression does not 
change. It is unknown by which mechanism 
the receptor expression is reduced. We can 
therefore only speculate about the reason for 
this difference. In contrast to 2B4 and NTB-
A, CRACC does not bind the adapter mole-
cule SAP [9]. Therefore, signaling events 
connected to recruitment of SAP may be in-
volved in the ligand-induced down-
modulation of 2B4 and NTB-A.  
Receptor engagement may not only result in a 
down-regulation of surface expression, but as 
already demonstrated for NKp30 [27] or 
NKG2D [25], also the expression levels of 
critical intracellular signaling molecules may 
be affected. We therefore wanted to test 
whether the expression of cytosolic proteins 
involved in SLAM-related receptor signaling 
is subject to modulation. To specifically ana-
lyze the expression of signaling molecules in 
NK cells we established a protocol to separate 
NK cells from the BA/F3 cells after 24 h of 
co-culture. Isolated NK cells were then lysed 
and the expression of the adapter molecules 
SAP and EAT-2 and the Src-family kinase 
FynT was analyzed by western blotting. No 
difference in expression levels of the three 
signaling molecules could be observed after 
co-culture of primary human NK cells with 
BA/F3 cells expressing CD48, NTB-A, 
CRACC or GFP as negative control (Fig. 2). 
These data demonstrate that the engagement 
of 2B4, NTB-A, or CRACC does not affect 
the expression levels of the critical intracellu-
lar signaling molecules SAP, EAT-2 or FynT. 
Therefore, the functional defects in 2B4-
mediated cytotoxicity after ligand engage-
ment which we previously described [19] are 
likely a result of ligand-induced receptor 
modulation and not of additional regulation of 
signaling molecule expression. However, we 
cannot exclude that the chronic stimulation of 
2B4, NTB-A or CRACC for more than 24 h 
might result in changes of SAP, EAT-2, or 
FynT expression levels. 
Stimulation of 2B4 leads to down-regulation 
of 2B4 surface expression ([19] and Fig. 1) 
resulting in reduced 2B4-mediated NK cell 
activation [19]. We therefore wanted to test if 
the engagement of NTB-A or CRACC also 
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had similar functional consequences. For this 
we used NK cells from the co-cultures with 
BA/F3 cells as effector cells in a chromium 
release assay against BA/F3 cells expressing 
NTB-A, CRACC or GFP as a negative con-
trol. Although we saw a down-regulation of 
NTB-A after the co-culture (Fig. 1), we could 
not detect a reduction in cytotoxicity when the 
NK cells were co-cultured with BA/F3 cells 
expressing NTB-A (resulting in the down-
regulation of NTB-A surface expression), 
compared to the co-culture with BA/F3-GFP 
control cells (Fig. 3A). Consistent with the 
fact that we did not see any down-regulation 
of CRACC or any important signaling mole-
cules after ligand engagement, we did not de-
tect any significant differences in CRACC-
mediated cytotoxicity (Fig. 3B).  
 
Figure 3: NTB-A and CRACC-mediated cytotoxic-
ity is not impaired after co-culture 
Co-cultures were performed as described for figure 1. 
(A) NK cells from co-cultures with BA/F3 GFP (left 
panel) or BA/F3 NTB-A (right panel) were used as 
effector cells in a 4 h 51Cr release assay against BA/F3 
GFP (open symbols) or BA/F3 NTB-A (black sym-
bols). The slight increase in cytotoxicity after co-
culture with BA/F3 NTB-A was not reproducible in 
subsequent experiments. (B) NK cells from co-culture 
with BA/F3 GFP (left panel) or BA/F3 CRACC (right 
panel) were used as effector cells against BA/F3 GFP 
(open symbols) or BA/F3 CRACC (black symbols). 
The specific lysis is shown as mean of triplicates for 
each effector to target ratio (E:T) ±SD. One representa-
tive of four experiments is shown. 
The increase of specific lysis conferred by the 
expression of CRACC on the target cells was 
only small, reflecting the comparatively weak 
activating potential of the CRACC receptor. 
This weaker signaling might explain the ab-
sence of ligand-induce modulation of CRACC 
expression. These data demonstrate that the 
regulation of receptor surface expression and 
function is different for the three members of 
the SLAM-related receptor family expressed 
on human NK cells. While CRACC expres-
sion and function remains unchanged after 
ligation, NTB-A and 2B4 show a reduced ex-
pression. However, while this reduction is 
sufficient to also affect 2B4-mediated NK cell 
activation, we did not see any reduction in 
NTB-A-mediated NK cell activation. This 
difference might be explained by the less pro-
nounced down-regulation of NTB-A surface 
expression, which may not be enough to sig-
nificantly affect the function of the receptor.  
Down-modulation of activating receptors is 
thought to be a regulatory mechanism adjust-
ing the threshold for activating signals in ar-
eas with high expression of activating ligands 
or attenuating NK cell responses after lysis of 
target cells. Our data show that this concept 
cannot be extended to all activating NK cell 
receptors, as NTB-A and CRACC do not 
show any functional modulation. Interest-
ingly, NTB-A and CRACC are the only ho-
mophilic NK cell receptors and may therefore 
also interact between neighboring NK cells. It 
may therefore be necessary for these receptors 
not to be modulated upon ligand engagement 
in order to preserve this interaction. 
 
Methods 
Cells 
Cells used in this study were polyclonal human 
NK cells (cultured in Iscove's modified Dul-
becco's medium supplemented with 10% human 
serum (PromoCell, Heidelberg, Germany), non 
essential amino acids, 1 mM sodium pyruvate 
(both from invitrogen, Carlsbad, CA, USA), peni-
cillin/streptomycin and recombinant IL-2 (NIH 
cytokine repository)), JY feeder cells and BA/F3 
cells stably transfected with cDNA of GFP, hu-
man CD48, human NTB-A and human CRACC 
(all cultured in RPMI1640, 10% FCS, 50 µM 2-
mercaptoethanol, penicillin/ streptomycin). The 
stably tranfected cell lines have been described 
previously [5]. 
Polyclonal human NK cells were obtained as fol-
lows: Peripheral blood mononuclear cells were 
isolated from buffy coats or whole blood using 
density centrifugation over lymphocyte separation 
medium (PAA, Pasching, Austria). Polyclonal NK 
cells were purified from peripheral blood mono-
nuclear cells using a NK cell negative isolation kit 
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(Dynal Biotech, Oslo, Norway). After isolation 
the cells were resuspended in culture medium 
containing 1 µg/ml PHA-P (Sigma, St. Louis, 
MO, USA) and 5 ng/ml recombinant human IL-15 
(R&D Systems, Minneapolis, USA), mixed with 
irradiated JY cells (5x105 cells/ml) and plated in 
96-well round bottom plates at densities ranging 
from 1x106 to 2x106 cells/ml. Growing cell cul-
tures were expanded 1:1 with culture medium. 
Experiments were performed with NK cells after 
three to four weeks of expansion. 
Co-culture 
IL-2-expanded primary human NK cells were 
mixed with BA/F3 cells at a density of 106 cells of 
each type per ml in NK cell culture medium and 
plated in 96-well round bottom plates. After 24 
hours cells were harvested and stained for flow-
cytometry or re-isolated for western blot analysis. 
Flow cytometry 
Cells were stained with PE-labeled antibodies 
against the respective receptors in combination 
with a PE-Cy5-conjugated antibody against CD56 
(clone B159, BD Biosciences Pharmingen, San 
Diego, CA, USA) to distinguish NK cells from 
remaining BA/F3 cells. Stained cells were ana-
lyzed on a FACScan cytometer (BD Biosciences). 
The following PE-conjugated antibodies were 
used: anti-2B4 (clone C1.7, Beckmann Coulter, 
Marseille, France), anti-CD48 (clone TÜ145, BD 
Biosciences Pharmingen) anti-NTB-A (clone NT-
7), anti-CRACC (clone 162.1), control antibody 
MOP-C21 (all three from BioLegend, San Diego, 
CA, USA). The relative fluorescence index (RFI) 
was calculated by subtracting the mean fluores-
cence intensity (MFI) of staining with the control 
antibody from the MFI of the specific staining and 
dividing the result by the MFI of the control stain-
ing: 
RFI = (MFI specific – MFI control) / MFI control 
Western blot 
For western blots NK cells were re-isolated from 
the co-cultures using human anti-mouse IgG anti-
body-coupled magnetic beads (Dynal Biotech, 
Oslo, Norway) and anti-CD56 antibody (clone 
MY31) (BD Biosciences Pharmingen). The re-
isolated cells were lysed in TNE buffer containing 
0.5% Triton-X 100 (20 mM Tris/Cl, pH 7.4, 
150 mM NaCl, 10% (v/v) glycerol 2 mM EDTA, 
1 mM PMSF, 0.5% (v/v) Triton X-100). Lysates 
were separated on 12% SDS NuPAGE gels (Invi-
trogen, Carlsbad, CA, USA) and blotted on poly-
vinylidene fluoride membrane (Millipore, 
Billerica, MA, USA). Memebranes were blocked 
with 5% non-fat dry milk in PBS containing 
0.05% Tween 20. The membranes were probed 
with the following antibodies: polyclonal rabbit 
antibodies anti-Fyn (Cell Signaling Technologies, 
Danvers, USA) and anti-actin (Sigma, St. Louis, 
MO, USA). Monoclonal mouse anti-SAP anti-
body and polyclonal rabbit anti-EAT-2 antibody 
have been described previously [15, 29]. Horse-
radish peroxidase-conjugated goat anti-mouse IgG 
(Jackson ImmunoResearch Laboratories; West 
Grove, PA, USA) or HRP-conjugated goat anti-
rabbit IgG (Santa Cruz Biotechnology, Heidel-
berg, Germany) respectively were used as secon-
dary antibodies. Bands were visualized using Su-
perSignal West Pico or Dura (Thermo scientific, 
Rockford, IL, USA) and X-ray films (Thermo sci-
entific). 
Chromium release assay 
Target cells were grown to mid-log phase, and 
5x105 cells were labeled in 100 µl of assay me-
dium (IMDM with 10% FCS and penicil-
lin/streptomycin) with 100 µCi of Na251CrO4 
(Hartmann Analytic GmbH, Braunschweig, Ger-
many) for 1 h at 37°C. Cells were washed twice in 
assay medium and resuspended at a density of 
5x104 cells/ml in assay medium. Five thousand 
target cells per well were used in the assay. NK 
cells from the co-cultures were resuspended in 
assay medium and were mixed with labeled target 
cells in a V-bottom 96-well plate at four different 
NK cell to target cell ratios. Maximum release 
was determined by incubating target cells in 1% 
Triton X-100. For spontaneous release, targets 
were incubated without NK cells in assay medium 
alone. All samples were done in triplicates. Plates 
were incubated for 4 h at 37°C. Supernatant was 
harvested, and 51Cr release was measured in a 
gamma counter. Percentage of specific release 
was calculated as ((experimental release –
 spontaneous release)/(maximum release –
 spontaneous release)) x 100. The ratio between 
maximum and spontaneous release was at least 4 
in all experiments. 
Statistical analysis 
Statistical analysis was performed using Prism 4 
(GraphPad Software, Inc., San Diego, CA, USA). 
Statistical significance was determined with one-
way ANOVA and Dunnet’s multiple comparison 
post-test. 
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